tutes for heart valves, the heart muscle and for vessels is pushed forward.
EnGinEERinG THE vA LvEs
Heart valve replacement remains an established form of surgical treatment for heart valve disease. There arebasically two different kinds of heart valve prostheses currently available: mechanical and bioprosthetic grafts. Both bears everal disadvantages. The main limitation of mechanical valves is the need for alifelong anticoagulation therapy of the patient due to the high thrombogenic potentialofthe used materials. This leads to an increased risk of haemorrhages. Bioprosthetic valves in contrast aren ot thrombogenic. Currently,these valve prostheses aremade out of chemically fixed xenogeneic or allogeneic tissue. However,o nly as hort lifetime of these grafts is reportedd ue to relative fast calcification and loss of functionality.O ne possible mechanism might be based on the antigenicity of the grafted tissue. The resultingconsequence is ashort lifetime of the prosthesis,w hich then has to be replaced. Furthermore, both mechanical and bioprosthetic valvesh ave no ability to be repaired and remodelled by thehost and arenot able to grow (3). Especially the lack of growth capacityi sat remendous drawback in paediatric heart surgery and causes the need for reoperations of heart valve substitutes in children. Apossible solution for these problems may evolvefromautologous grafts -tissue engineered heart valves give the promise to be non thrombogenic, and due to their viability have the potential to underlie all remodellingp rocesses in the body.Asaresult, the use of tissue engineered heart valves may avoid the need for repeated valve replacement surgery.
MATRiCEs
The morphology of the native heart valve at the cellular level is relatively simple: endothelial cells (EC) cover the surface while interstitial cells reside in the Cardiovascular diseases arethe number one cause of death globally (1). But at the time, for am ajority of the acquired or congenital diseases asufficient form of therapy is missingand oftentimes acardiac substitute is needed to overcome cardiovasculard iseases. However,d onor organs arer area nd common prostheses have several disadvantages. As an alternative solution to resolve these problems, tissue engineering is under discussiona si tp romises to "re-engineer" human tissues and organs. Adefinition of tissue engineering was given by The Biomedical Engineering Handbook (2): "The application of scientific principles to the design, construction,modification, growth and maintenance of living tissue."
Tissue engineering includes three main topics for the generation of artificial living tissue: 1) Biomaterials to create matrices, which give 3-dimensionald esign and mechanical properties to the construct. 2) Cell culture and molecular biology to provide cells specific for the counterpart of native tissue. 3) Biotechnology and bioengineering principles are needed to create bioreactor assemblies that provide in vitro conditions similar to those in vivo; including adjustment of pH, temperature, nutrient and oxygen supply,a nd if needed as et-up for physical stress stimuli like shear stress, mechanical tensionorelectrical stimulation.
With recent improvements in these fields, tissue engineering now is very promising for the futuretreatment of several diseases. specially to overcome cardiovasculardiseases, the research to generate substi-extracellular matrix (ECM). The substrates ares upplied by the blood stream in the lumen of the vessel and distributed by diffusion processes. Capillaries areonly found in the outer wall. in contrast to most organs and tissue in the human body,the functionality of the heart valve is barely given by aspecial assembly of cells of different types. it is mostly the ECM that sets up functionality of the heart valve. As native heart valve in its natural position has to withstand physical forces like tension, shear stress, and pressure, the mechanicalstability of the matrix is the main featureofthe heart valve. in this regardthe choice of the right matrix is the criticalpoint in heart valve tissue engineering.T he chosen matrix should be biocompatible, provide similar haemodynamic properties as the native tissue does,a nd should also have adequate abilities for cell seeding and proliferation processes. Twom ain types of scaffolds arei nu se: matrices based on synthetic polymers and those of decellularized biological tissues. Biological matrices aregenerated out of native allogeneic (4) or xenogeneic (5) heart valves, and have several advantages like good seeding-properties,s imilar mechanical properties compared to native heart valves, biocompatibility, and native 3-dimensional composition (3).
The use of synthetic biodegradable polymers necessitates amoulding of the polymer to afunctional valve construct that can be seeded with cells. The main idea in this approach is that cells seeded on scaffold will degrade and afterwards reconstruct the synthetic matrix to generate a de novo autograft with haemodynamic properties similar to native heart valves (6).
CELLs AnD CuLTivATiOn PROCEDuREs it is well known that viabilitya nd functionality of endothelial cells (EC) ared ependent on their exposuret os hear stress (7). As EC loose their status of differentiation under static conditions, EC seeded and propagated on valve matrices should be exposed to biomimetic shear stress in vitro beforet heir application in vivo.For that reason acouple of different bioreactor assemblies wered esigned to simulate pressurea nd flow conditions of the heart in vitro like those described by us (8) (Fig. 1 ) and others (9).
in respect to clinical application, investigators started to use autologous-derived EC. Autologous cells for usage in heart valve tissue engineering may be obtainedf romt he patients' own blood vessels, blood and bone marrow (10) . in addition, therea re new methods of tissue sampling, which allow cell harvesting after birth and evenduring the gestational period (11) . This means that congenital heart valve defects can be surgicallyc orrected by constructing heart valves seeded with autologousc ells isolated during pregnancy or directly after birth. in summary,t issue engineeringo fh eart valves with proper haemodynamic characteristics, growth potential, and durabilitymay be the key to overcome major complicationso fc ommon heartv alve prostheses.
EnGinEERinG THE MusCLE
The treatmento fc ardiac insufficiency caused by myocardial infarction, dilational cardiomyopathy or by virus infection is mostly dependent on heart transplantation of donor organs or mechanicals upport with artificial devices. The high risk of rejection, infection and rarity of organ donors have provided a great incentivet od evelop new approaches for the generation of myocardial tissue. Tissue engineered cardiac muscle constructs could be apromising alternative to whole heart transplantation. Fig. 1 . Pulmonary heart valve in abioreactor.Pulsatile flow mimics physiological conditons and is required for complete stable endothelialization.
CELL sOuRCEs
The rise of the idea to create artificial myocardial tissue might have come up with the first observations of neonatal cardiomyocytes taken from chicken or rat, and cells werebeating in culture. Although these cell types arei nvaluable for designing cultures ystems, for aclinical application autologous or allogeneic cell sources areneeded. since adult differentiated cardiomyocytes aren ot able to divide, it is not possible to harvest and cultivate as ufficient amount of autologous cardiomyocytes for the generation of artificial myocardial tissue out of asmall biopsy.Even, to get amyocardial biopsy might be difficult per se.
The usage of stem cells could overcome this problem, as they area ble to proliferate and differentiate into cardiomyocytes. Different sources of stem cells arepresently under investigation for the application in myocardial restoration like bone marrow,h aematopoieticaswell as embryonic stem cells. Autologous cardiomyocytes might also be obtained by the isolation, cultivation and differentiationo fc ardiac progenitor cells from biopsiesofthe heart (12) .
Although it seems to be possible to differentiate functional cardiomyocytes out of different types of stem cells, some grave problems areremaining yet: it is difficult to select differentiated cardiomyocytes from other undifferentiated cells, it is also difficult to propagate them sufficiently,a nd they might cause teratomas in the host (13) .
MECHAniCAL AnD ELECTRiCAL sTiMuLATiOn in native myocardium, cardiomyocytes area ligned following the running direction of the electrical signal. To achieve functional cardiomyocyte constructs as imilar alignment has to be supported in the culture, not only to achievead irected electrical signal but also to keep the differentiationstatus of the cells, as alignment and differentiationa re related to each other.B oth can be achieved by bringing "stress" to the culture. For this purpose bioreactor assemblies for artificial heart tissue wered eveloped to provide either mechanical (14, 15) or electrical stimulation (16) . Both methods,mechanical and electrical stimulation, wereable to enhance alignment and functionality of 3-dimensional cardiac tissue constructs.
Beside complex bioreactor assemblies, it is likewise possible to generate ad irected and electrically coupled cardiomyocyte culturew ithout stimulation by just using ap atterned matrix. For instance, decellularized small intestinal submucosa (sis)f eatures aligned collagen fibres. seeding of sis with cardiomyocytes leads to an alignment along the fibreorientation resultingi nad efined contraction direction. The contraction in turn gives rise to am echanical stimulustothe culture(own unpublished results).
MATRiCEs AnD nuTRiEnT suPPLy
The functionality of cardiomyocytes is highly dependent on as ufficient nutrient and oxygen supply.i n native myocardium each cardiomyocyte is in contact with at least one capillary.Therefore, it is not possible to create af unctional myocardial construct without given special attention to this detail (17) . The effective supply of 3-dimensional tissue, however,isfaced by most tissue engineering applications.
Porous polymer based scaffolds areused by many groups for generating artificial myocardial tissue. in these scaffolds the substrate supply is supported by diffusion process only.A sac onsequence, the thickness of the construct is highly restricted. For clinical application indeed the size of the construct has to match at least the thickness of the right human ventricle. some groups tried to overcome the problem by supplying the scaffold by medium perfusion (18) . unfortunatelythese approaches do not show the requested efficiency for the nourishment of constructs with aclinical relevant thickness.
To reach asupplying efficiency comparable to those of native vessel-beds, the in vitro generationofafunctionalv essel-bed is still ap romising goal in tissue engineering. Anew approachtoreach that goal is the in vivo-vascularisation of artificial myocardial constructsi ni mplantedc ages in ah ost (19) .A nother approach is the reseeding of ad ecellularized native vessel-bed with EC to create an autologous vesselnetwork in vitro .T his promising method has been developedi no ur lab (Fig. 2) and is under intense investigation. Previous concepts to develop artificial myocardial tissue werea ctually successfuli ng enerating 3-dimensionalc onstructs with af avoured alignment of cells and asatisfying functionality (20, 21) . nevertheless, ac ardiac construct with as uitable thickness to repair ah uman ventricle is missing. For these purposes as ufficient method for nutrients and oxygen supply needs to be established.
EnGinEERinG THE vEssEL
Coronary artery bypass operations arer equesting suitable vessels that can serve as grafts. For treatment of ischemic cardiomyopathy two different kinds of constructs arei nu se. some patients can receive autologousgrafts derived from v. saphena or A. mammaria interna. Although these prosthesesa re fully biological, they underlie changes in wall structure and due to that they have to be replaced after 6t o8 years. Available synthetic grafts arebased on mostly synthetic polymers like PTFE or PET.They provide a comparable mechanical stability of a native vessel but the artificial structurec auses especially in small diameter grafts thrombogenicity and intimal proliferation. For vesselreplacement, in particular for smaller vessels, the hope to overcome common complications is given by tissue engineered vessel grafts.
CELLs AnD CuLTuRE COnDiTiOns
The main properties of av essel areg iven by EC. By lining the lumen these cells areaccountable for sheltering the vessel from undesired thrombogenic processes, and avoiding asprouting of cells into the lumen. Due to that fact, first approaches to create a tissue engineered vessel weretoseed EC on common used syntheticscaffolds (22) . The results showed improved properties of the graft compared to antithrombogenic coated synthetic vessels. However, degradation products of these polymersh ave cancerogenic potential in the host. in an ext step, scaffolds based on naturally derived materials like collagen were tested (23) . Buteven withdifferentmodifications in chemical structuret hese constructs showed insufficient stability.A sE Ca re responsible for biological integrity of the vessel, smooth muscle cells arefor mechanical features by building the ECM of the wall. On this account, co-cultures of EC and smooth muscle cells werea ccomplished to promote better mechanical properties as tested with decellularized vein scaffolds (24) (Fig. 3 ).
BiOREACTOR AssEMBLiEs
Pulsatilestress is known to achievethe typical lining of the EC and condition their differentiation state (7); bioreactors werea ssembled to provide shear stress and pulse stimulation for seeded EC like it occurs in nativev essels. FurthermoreK anda and co-workers showed that cyclic stretch of smooth muscle cells indicates areversion of these cells to amorecontractile phenotype (25) .This leads to the development of bioreactor devices with the property to stretch the outer wall of the vascular graft. Appending approaches showed an enhancedstiffness of the constructs (26) .
At least ap athbreaking work was published by niklason and co-workers:b iodegradable polyglycolic acid scaffolds wereseeded with smooth muscle cells and exposed to cyclic stretch to achieve avessel wall with certain mechanical strength. Further on, the vessel lumen was seeded with EC under physiological pulsatile conditions. The construct was comparable to anative vessel in constitution and mechanical properties (27) .
CELL sOuRCEs
To construct aprosthesis for clinical applications the question of an applicable cell source rises again. As a solutionf or this problem the isolation of circulating endothelial progenitor cells (EPC) from patient blood to line the inner lumen of the vessel was considered. Admittedly,t his solution suffers from certain drawbacks.Firstly,the amount of circulating EPC seems to be diminished in patients with vascular diseases.secondly, the isolation and proliferation of these cells up to arequired amount that is needed for reseeding the grafts takes several weeks. Therefore, such constructs would not be quick at hand. As an alternative, differentiated EC werei solated and propagated from segments of thes aphenous vein (28) . in paediatric surgery,h owever,t his seems not to be ar easonable cell source, but as already discussed in the valve sec- tion, cells isolated from the umbilical cordoreven the amnionic fluid might be used.
Currently a new method was presented to generate vascular grafts using a cell sheet culture model. These grafts weresuccessfully tested in animal models (29) . This work is characteristic for the field of engineering vessel grafts as it shows another prosperous and highly advanced approach. Although an applicable construct of small diameter vessel prostheses is still missing at present, tissue engineering of vessel is considered to be themost advanced field in cardiovascular tissue engineering.
COnCLusiOn AnD PROsPECTs
Although al ot of research was performed and tremendous progress was made in the field of cardiac tissue engineering, the big goal is not reached yet. But whered ow es tand now? in fact, we would like to repair and reverse engineer an engine that we haven't created and the service manual is missing as well. We do not know exactlywhich materials we have to use. Biologicalm aterials, cells and the ECM, aren ot behaving as "simple" as inorganic materials, because of their intense communication with their environment through complicated and mostlyu nknown (path-) ways. On aclose look, every single cell we areusing is amotorand adesigner of the whole tissue by itself. And in turn, cells arehighly dependent on aspecific architectureofcells and ECM and adynamic flow of communicationinthe system to obtain acertain status of differentiationand to persist in it.
it seems to be almost impossible that aman-made cell cultures ystem can fulfil all these requirements. However,c onstructs generated today may serve in the futureasavenues to answer remaining questions and solve remainingp roblems to reach the big aim: being successful in engineering the perfect machine, the motor of life.
